Cancer medicines
Pertuzumab
Pertuzumab
An antibody used in combination treatment for HER2-positive breast cancer.
Sources checked · Introductory guide
On this page
How it works
It binds HER2 and inhibits receptor pairing and growth signaling.[3]
Where it is used
Combined with other anti-HER2 medicines or chemotherapy in selected perioperative or metastatic HER2-positive breast cancer settings.[1]
Key safety points
Heart function is monitored before and during treatment. Report new breathlessness, swelling, rapid weight gain or infusion reactions immediately.[2]
Questions for your care team
- What are my HER2 result, combination medicines and heart ultrasound schedule?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
- NCI · Pertuzumab (opens in a new tab)
- MedlinePlus · Pertuzumab (opens in a new tab)
- NCI Drug Dictionary · Pertuzumab (opens in a new tab)
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.